Research Day School Mental Health and Neuroscience 2019
Research Day School Mental Health and Neuroscience 2019

Overview E-pitches

Click on the title to go to the abstract

Screen 1 Chair: Jaap Jansen  
  Neuroimaging    
Time Last name Title of contribution: Annexe
13:00 Kerkhof, Marieke van den Detection of high-frequency pulsations in the brainstem using resting-state fMRI at 7 Tesla  
13:10 Canjels, Lisanne Assessing Blood-Brain Barrier permeability at 7T: proof of principle in a cortical ischemic stroke patient  
13:20 Duggirala, Suvarnalata Xanthate Emotional self-voice processing and its relationship with hallucinatory proneness: preliminary ERP evidence  
13:30 Hooren, Roy van The association between 3-Methoxy-4-hydroxyphenylglycol levels and cortical thickness in a clinical memory population  
13:40 Lionarons, Judith Reading performance in relation to white matter network connectivity detected with MRI in Duchenne muscular dystrophy  
13:50 Monereo Sanchez, Jennifer Quality control of structural MR brain images in the Maastricht Study  
14:00 Mons, Martijn Analysis of  brain chemistry using MALDI-TOF mass spectrometry imaging in a rat model of chronic neuropathic pain  
14:10 Thiel, Merel van der Glymphatic dysfunction in cognitive impairment: design for a cross-sectional memory clinic study  
14:20 Vergoossen, Laura How white matter matters - The Maastricht Study  
14:30 Verheggen, Inge Blood-brain barrier integrity: The key to successful cognitive aging?  
14:40 Voulgaropoulou, Stella Social Cognition in Psychosis: Adapting a behavioral task for fMRI purposes  
14:50 You, Wenting The Destiny of Dying Retinal Ganglion Cells in Glaucoma  
       
Screen 2 Chair: Caroline van Heugten  
  Rehabilitation    
Time Last name Title of contribution: Annexe
13:00 Everdingen, Coline van A comprehensive assessment of the homeless:new means of shaping public mental health  
13:10 Rauwenhoff, Johanne Are negative trials really negative?
Analyzing the data of a randomized controlled trial from an individual perspective		  
       
  Chair: Jos Prickaerts  
  Pharmacology    
Time Last name Title of contribution: Annexe
13:20 Bertens, Christian Safety, comfort and retention of the ocular coil - results from the first-in-man trial.  
13:30 Pacheco Pachado, Mayra From symptom- to mechanism-based definition of dementia endophenotypes and comorbidities for precision diagnosis and curative therapy  
13:40 Mané Damas, Marina Targeting Plasma Cells with Proteasome Inhibitors for Treatment of Myasthenia Gravis   
13:50 Mechelen, Ralph van SEAMS; the usage of animal models in GFS research for the development of new treatment modalities.  
14:00 Nelissen, Ellis Soluble guanylate cyclase stimulator vericiguat enhances memory processes through GluA1-AMPA receptor trafficking  
14:10 Schepers, Melissa Phosphodiesterase 4D inhibition boosts remyelination in multiple sclerosis  
14:20 Wolters, Jarno SEAMS; an update on a drug delivery system for glaucoma filtration surgery  
14:30 Foulquier, Sebastien Type 2 Diabetes and Obesity accelerate the activation of Vessel-Associated Microglia in hypertensive rats  
       
       
Screen 3 Chair: Kay Deckers  
  Prevention    
Time Last name Title of contribution: Annexe
13:00 Geraets, Anouk The Association Of Hyperglycemia And Insulin Resistance With Incident Depressive Symptoms Over 4 Years Of Follow-up: The Maastricht Study  
13:10 Heger, Irene Raising awareness of dementia risk reduction: Results of an eHealth-based public health campaign  
13:20 Mulders, Anne Finding balance: towards improved psychosocial patient management following DBS surgery in Parkinson's disease  
13:30 Pagen, Linda Pilot Study: Stress and memory performance in older individuals  
13:40 Strekalova, Tatyana Genetic SERT deficiency exacerbates metabolic and behavioural effects of Western diet in aging mice: the role of pro-inflammatory and mitochondrial regulators  
13:50 Tripathi, Priyanka Autophagy dysfunction and alterations of RNA binding protein homeostasis in vacuolar myopathies  
14:00 Verberne, Daan Early cognitive and emotional outcome after stroke is independent of discharge destination  
14:10 Bruinsma, Jeroen An online support program for partners and other family members of you people with dementia  
14:20 Yamoah, Alfred The endoplasmic reticulum (ER) co-chaperone SIL1 in human sporadic (s) and familial (f) ALS  
       
  Chair: Annelien Duits  
  Behavioral therapy    
Time Last name Title of contribution: Annexe
14:30 Damci, Aysun Psychological Approach To Control The Pain In Small Fiber Neuropathy  
14:40 Kort, Anne Rose de Neonatal procedural pain and long-term consequences on anxiety related behaviours in rats  
       
Screen 4 Chair: Marjan Drukker  
  ESM/ehealth    
Time Last name Title of contribution: Annexe
13:00 Bartels, Sara Laureen A Narrative Synthesis Systematic Review of Digital Self-Monitoring Interventions for Middle-Aged and Older Adults  
13:10 Christie, Hannah eHealth interventions to support caregivers of people with dementia may be proven e ective, but are they implementation-ready? Annexe
13:20 Daemen, Maud An introduction to a novel self-esteem Ecological Momentary Intervention in traumatized youth: The SELFIE-study  
13:30 Daniëls, Naomi Successful long-term engagement in self-monitoring using e-diaries: A scoping review  
13:40 Goossens, Evita Momentary subjective well-being and psychotic experiences during antipsychotic dose-reduction: a pilot study  
13:50 Heijmans, Margot Monitoring Parkinson’s disease symptoms during daily life: A feasibility study  
14:00 Hellebrekers, Danique Working memory training in Duchenne muscular dystrophy  
14:10 Verhagen, Simone Cognition in everyday Life - feasibility, validation, and lessons-learned  
       
  Chair: Mario Losen  
  Diagnostics    
Time Last name Title of contribution: Annexe
14:20 Domensino, Anne-Fleur A conceptual consideration of measuring cognition on the spectrum: from tests to daily life  
14:30 Gruters, Angélique An exploratory study of the development of an interactive visualization tool of neuropsychological performances.  
14:40 Zong, Shenghua Detection of Glutamic acid decarboxylase (GAD) and other neuronal autoantibodies in suspected GAD related disorders  
       
Screen 5 Chair: Ali Jahanshahi  
  Neuromodulation    
Time Last name Title of contribution: Annexe
13:00 Alzate Sanchez, Ana Maria Impact of anesthesia in the microelectrode recordings during deep brain stimulation for Parkinson Disease patients.  
13:10 Baldi, Samantha The Effects of Deep-Brain Non-Stimulation in Severe Obsessive-Compulsive Disorder: an Individual Patient Data Meta-Analysis  
13:20 Devos, Jana Deep Brain Stimulation for refractory tinnitus Annexe
13:30 Douven, Perla Defecation behavior in an experimental rat model of fecal incontinence  
13:40 Franken, Glenn Nonlinear relation between BurstDR™ dorsal root ganglion stimulation amplitude and behavioral outcome in an experimental model of painful diabetic peripheral neuropathy  
13:50 Habets, Jeroen Machine learning prediction of motor response after deep brain stimulation in Parkinson's disease  
14:00 Heijmans, Lonne GABA-ergic neurotransmission in the spinal Pain Gate is not structurally changed after Long-term SCS in experimental PDPN.  
14:10 Liu, Huajie Nucleus basalis of Meynert (NBM) DBS in a rat model of experimental dementia: the role of stimulation parameters  
14:20 Luo, Qian Neuronal over-expression of the ceramide transfer protein (CERTL) increased sphingomyelin and reduced amyloid-β levels and inflammation by diminishing amyloid precursor protein cleavage in a mouse model of Alzheimer’s disease  
14:30 Pol, Sylvana Decreased calcium activity in the dorsal raphe nucleus during deep brain stimulation of the subthalamic nucleus in freely moving mice Annexe
14:40 Thomson, Alix Modelling human neurons with the SH-SY5Y cell line-an application to non-invasive brain stimulation research  
14:50 Rombaut, Rombout Locus impairment of DISC1 results in cognitive deficiency in rodents  
       
Screen 6 Chair: Pieter Jelle Visser  
  Biomarkers    
Time Last name Title of contribution: Annexe
13:00 Bakker, Lieke Correlations of Plasma Kynurenines with CSF Levels, and their relation to Markers of Alzheimer’s Disease Pathology and Diagnostic Phases.  
13:10 Banning, Leonie The predictive value of Alzheimer’s disease biomarkers for trajectories of depression and apathy  
13:20 Boonstra, Jackson Construction of dedicated container for postmortem human brain ultra-high field magnetic resonance imaging Annexe
13:30 Choe, Kyonghwan (Chris) Unraveling the dysregulated tryptophan pathway in AD: A look into the (epi)genetics  
13:40 Hubens, Wouter Plasma GDF-15 concentration in primary open-angle glaucoma patients  
13:50 Janssen, Olin Predictors of amyloid positivity in persons with subjective cognitive decline  
14:00 Kruining, Daan van Plasma Ceramides and its Transporter Protein CERT in Association with Brain Atrophy in Mild Cognitive Impairment  
14:10 Mohile, Tanya Myasthenia gravis thymus, blood and bone marrow cell cultures as a laboratory test to predict immunosuppression treatment efficacy  
14:20 Snijders, Clara Circulating serum microRNAs as potential diagnostic biomarkers of post-traumatic stress disorder: A pilot study  
14:30 Munter, Hans de Neuro-Cell therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice  
14:40 Almasabi, Faris Tinnitus animal model activity changes with and without deep brain stimulation.   
       
Screen 7 Chair: Laurence de Nijs  
  Genetics    
Time Last name Title of contribution: Annexe
13:00 Bassil, Katherine Investigating the effects of cortisol on RNF39: an in vitro model of traumatic stress  
13:10 Burgt, Nikita van de Screening for inborn errors of metabolism in psychotic patients using Next Generation Sequencing  
13:20 Cinar, Ozan Statistical Problems in Gene-Based Testing and Possible Solutions  
13:30 Giovagnoni, Caterina The role of altered sphingolipid function in Alzheimer’s disease; a gene regulatory network approach.  
13:40 Guo, Le Gene editing approaches for Myotonic Dystrophy Type 1 using CRISPR/Cas9 ribonucleoprotein and mesoangioblasts  
13:50 Joosten, Isis Parental repeat length instability in myotonic dystrophy type 1 pre- and protomutations  
14:00 Koulousakis, Philippos In vitro and in vivo epigenetic editing of Oxt in Alzheimer's disease  
14:10 Paes, Dean Altered transcriptional control of PDE4D isoforms in Alzheimer’s disease  
14:20 Tiane, Assia Relieving the epigenetic blockade in progressive MS: making remyelination accessible again  
       
No presentation    
  Last name Title of contribution: Annexe
  Casas Guijarro, Ana Network pharmacology-based therapeutic approach for brain ischemia" Annexe
  Riemens, Renzo Single cell profiling in Alzheimer's disease demonstrates opposite dysregulation in methylation patterns in serotonergic neurons as compared to dorsal raphe bulk tissue  
  Schichel, Mignon Senior Friendly Communities: a five step approach to making municipalities’ health policies more friendly towards people with dementia and depression